These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 28381093)

  • 1. Rat Models of Ventricular Fibrillation Following Acute Myocardial Infarction.
    Hundahl LA; Tfelt-Hansen J; Jespersen T
    J Cardiovasc Pharmacol Ther; 2017 Nov; 22(6):514-528. PubMed ID: 28381093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rationale of therapy in the patient with acute myocardial infarction and life-threatening arrhythmias: a focus on bretylium.
    Lucchesi BR
    Am J Cardiol; 1984 Jul; 54(2):14A-19A. PubMed ID: 6380259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amiodarone Treatment in the Early Phase of Acute Myocardial Infarction Protects Against Ventricular Fibrillation in a Porcine Model.
    Sattler SM; Lubberding AF; Skibsbye L; Jabbari R; Wakili R; Jespersen T; Tfelt-Hansen J
    J Cardiovasc Transl Res; 2019 Aug; 12(4):321-330. PubMed ID: 30617762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Preventive antifibrillatory treatment of sudden cardiac death in acute myocardial infarct].
    Thale J; Gülker H; Hindricks G; Haverkamp W; Pollock B; Buchwalsky R
    Z Kardiol; 1988; 77 Suppl 4():11-22. PubMed ID: 3062962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comprehensive review and analysis of 25 years of data from an in vivo canine model of sudden cardiac death: implications for future anti-arrhythmic drug development.
    Billman GE
    Pharmacol Ther; 2006 Sep; 111(3):808-35. PubMed ID: 16483666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Ischemic disorders of cardiac rhythm: effects of the autonomic nervous system on electrophysiologic findings and pharmacotherapy].
    Gülker H; Thale J
    Z Kardiol; 1986; 75 Suppl 5():15-34. PubMed ID: 3825228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HBI-3000 prevents secondary sudden cardiac death.
    Lee JY; Lucchesi BR
    J Cardiovasc Pharmacol Ther; 2013 Sep; 18(5):453-9. PubMed ID: 23615576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preclinical assessment of antiarrhythmic drugs.
    Lucchesi BR; Lynch JJ
    Fed Proc; 1986 Jul; 45(8):2197-205. PubMed ID: 3720962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ivabradine is as effective as metoprolol in the prevention of ventricular arrhythmias in acute non-reperfused myocardial infarction in the rat.
    Marciszek M; Paterek A; Oknińska M; Mackiewicz U; Mączewski M
    Sci Rep; 2020 Sep; 10(1):15027. PubMed ID: 32929098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacological possibilities for the prevention of complications following myocardial infarction].
    Szekeres L
    J Pharmacol; 1986; 17 Suppl 2():65-81. PubMed ID: 3821131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ventricular arrhythmias: medical therapy, device treatment, and indications for electrophysiologic study.
    Sager PT; Batsford WP
    Cardiol Clin; 1988 Feb; 6(1):37-47. PubMed ID: 3048673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiarrhythmic versus antifibrillatory actions: inference from experimental studies.
    Lucchesi BR; Chi L; Friedrichs GS; Black SC; Uprichard AC
    Am J Cardiol; 1993 Nov; 72(16):25F-44F. PubMed ID: 8237827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Role of antiarrhythmics in the post-infarction period].
    Dinanian S
    Arch Mal Coeur Vaiss; 2000 Apr; 93(3 Spec No):65-9. PubMed ID: 10816803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The anti-arrhythmia activity of quinazopyrine].
    Stets VR; Beregovaia EG; Dunaev VV; Storozhuk BG; Favoritov VN; Stoliarchuk AA; Mazur AI
    Farmakol Toksikol; 1990; 53(3):15-7. PubMed ID: 2387373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Class I and III antiarrhythmic drugs for prevention of sudden cardiac death and management of postmyocardial infarction arrhythmias. A review.
    Vrana M; Pokorny J; Marcian P; Fejfar Z
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2013 Jun; 157(2):114-24. PubMed ID: 23681306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological modification of arrhythmias after experimentally induced acute myocardial infarction. Drugs acting on the nervous system.
    Lucchesi BR; Kniffen FJ
    Circulation; 1975 Dec; 52(6 Suppl):III241-7. PubMed ID: 1182977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relation of mortality to failure to prescribe beta blockers acutely in patients with sustained ventricular tachycardia and ventricular fibrillation following acute myocardial infarction (from the VALsartan In Acute myocardial iNfarcTion trial [VALIANT] Registry).
    Piccini JP; Hranitzky PM; Kilaru R; Rouleau JL; White HD; Aylward PE; Van de Werf F; Solomon SD; Califf RM; Velazquez EJ
    Am J Cardiol; 2008 Dec; 102(11):1427-32. PubMed ID: 19026290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indications for antiarrhythmic therapy as prophylaxis against sudden death.
    Peter T; Hamamoto H; Jordon J; Platt M; Mandel W
    Cardiovasc Clin; 1980; 11(1):249-66. PubMed ID: 7002303
    [No Abstract]   [Full Text] [Related]  

  • 19. [Ventricular arrhythmias and sudden cardiac death in acute myocardial infarct in the era of thrombolytics].
    Jurkovicová O; Spitzerová H; Cagán S
    Bratisl Lek Listy; 1997; 98(7-8):379-89. PubMed ID: 9471331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A study of ventricular arrhythmias associated with acute myocardial infarction in the canine heart.
    Waldo AL; Kaiser GA
    Circulation; 1973 Jun; 47(6):1222-8. PubMed ID: 4709538
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.